Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal

L Majoros1, G Kardos, B Szabó

  • 1Department of Medical Microbiology, University of Debrecen, 4032 Debrecen, Nagyerdei krt. 98, Hungary. major@jaguar.dote.hu

Insights

Caspofungin effectively kills Candida inconspicua, showing a good fungicidal effect. Researchers recommend using the partial inhibition endpoint for accurate minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) testing.

Area of Science:

  • Medical Mycology
  • Antifungal Drug Susceptibility Testing

Background:

  • Candida inconspicua is an emerging fungal pathogen.
  • Echinocandin antifungals like caspofungin are crucial for treating invasive candidiasis.
  • Accurate susceptibility testing is vital for guiding therapy.

Purpose of the Study:

  • To determine the minimal inhibitory concentrations (MICs) and minimal fungicidal concentrations (MFCs) of caspofungin against Candida inconspicua.
  • To evaluate the impact of different endpoint criteria on caspofungin MIC and MFC determination.

Main Methods:

  • Minimal inhibitory and fungicidal concentrations were determined for 48 Candida inconspicua isolates.
  • CLSI (Clinical and Laboratory Standards Institute) methodology was employed.
  • Both partial inhibition and total inhibition endpoint criteria were assessed.

Main Results:

  • Caspofungin demonstrated a potent fungicidal effect against C. inconspicua.
  • The MIC(90) was 0.25 microg/ml and the MFC was 0.5 microg/ml at 24 hours using the partial inhibition endpoint.
  • Total inhibition criteria resulted in falsely elevated MICs, which exceeded the MFCs.

Conclusions:

  • Caspofungin exhibits significant fungicidal activity against Candida inconspicua.
  • The partial inhibition endpoint is recommended for accurate caspofungin susceptibility testing of C. inconspicua.
  • Using total inhibition endpoints can lead to inaccurate and misleading susceptibility results.